{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:38:30Z","timestamp":1788871110653,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health and Welfare, Republic of Korea","award":["A100304"],"award-info":[{"award-number":["A100304"]}]}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.canlet.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T12:39:06Z","timestamp":1410007146000},"page":"390-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["SMILE upregulated by metformin inhibits the function of androgen receptor in prostate cancer cells"],"prefix":"10.1016","volume":"354","author":[{"given":"Seung-Yon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hee","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Bin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaeyong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hueng-Sik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keesook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2014.09.001_bib0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0344-0338(96)80097-5","article-title":"The androgen receptor in prostate cancer","volume":"192","author":"Trapman","year":"1996","journal-title":"Pathol. Res. Pract"},{"key":"10.1016\/j.canlet.2014.09.001_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jcb.10653","article-title":"Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence","volume":"91","author":"Taplin","year":"2004","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/j.canlet.2014.09.001_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc801","article-title":"A history of prostate cancer treatment","volume":"2","author":"Denmeade","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2014.09.001_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","article-title":"The development of androgen-independent prostate cancer","volume":"1","author":"Feldman","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2014.09.001_bib0030","first-page":"175","article-title":"Prostate cancer: the role of hormonal therapy","volume":"24","author":"Salesi","year":"2005","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.09.001_bib0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G","article-title":"Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer","volume":"28","author":"Denmeade","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2014.09.001_bib0040","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/jnci\/91.21.1869","article-title":"Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence","volume":"91","author":"Agus","year":"1999","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2014.09.001_bib0045","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.canlet.2014.09.001_bib0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2014.09.001_bib0055","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1200\/JCO.2002.10.018","article-title":"Molecular biology of the androgen receptor","volume":"20","author":"Gelmann","year":"2002","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0960-0760(92)90402-5","article-title":"Functional domains of the human androgen receptor","volume":"41","author":"Jenster","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0960-0760(99)00049-7","article-title":"Mechanisms of androgen receptor activation and function","volume":"69","author":"Brinkmann","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol"},{"issue":"Pt 3","key":"10.1016\/j.canlet.2014.09.001_bib0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj2930761","article-title":"Nuclear import of the human androgen receptor","volume":"293","author":"Jenster","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2014.09.001_bib0075","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1016\/S0021-9258(17)36806-0","article-title":"A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences","volume":"269","author":"Zhou","year":"1994","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.09.001_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(98)00145-2","article-title":"Coactivators and corepressors as mediators of nuclear receptor function: an update","volume":"143","author":"Jenster","year":"1998","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/edrv.23.2.0460","article-title":"Androgen receptor (AR) coregulators: an overview","volume":"23","author":"Heinlein","year":"2002","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.canlet.2014.09.001_bib0090","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2014.09.001_bib0095","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"358","author":"Marchesini","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2014.09.001_bib0100","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1210\/jc.2006-0336","article-title":"Metformin treatment to prevent early puberty in girls with precocious pubarche","volume":"91","author":"Ibanez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2014.09.001_bib0105","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2014.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s10552-009-9407-y","article-title":"Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study","volume":"20","author":"Wright","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canlet.2014.09.001_bib0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2012.12.004","article-title":"Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality","volume":"63","author":"Spratt","year":"2013","journal-title":"Eur. Urol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2014.04.027","article-title":"Metformin use and prostate cancer risk","author":"Preston","year":"2014","journal-title":"Eur. Urol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0125","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.09.001_bib0130","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","article-title":"Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells","volume":"70","author":"Ben Sahra","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.09.001_bib0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2217\/nnm.11.61","article-title":"Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the antitumor effect of metformin in prostate cancer cells","volume":"7","author":"Monteagudo","year":"2012","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.canlet.2014.09.001_bib0140","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/nar\/28.12.2446","article-title":"Zhangfei: a second cellular protein interacts with herpes simplex virus accessory factor HCF in a manner similar to Luman and VP16","volume":"28","author":"Lu","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.canlet.2014.09.001_bib0145","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1128\/JVI.79.23.14708-14718.2005","article-title":"The neuronal host cell factor-binding protein Zhangfei inhibits herpes simplex virus replication","volume":"79","author":"Akhova","year":"2005","journal-title":"J. Virol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0150","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbrc.2005.11.139","article-title":"Identification and characterization of the DNA-binding properties of a Zhangfei homologue in Japanese pufferfish, Takifugu rubripes","volume":"339","author":"Cockram","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2014.09.001_bib0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.febslet.2005.11.046","article-title":"Cooperative interaction of Zhangfei and ATF4 in transactivation of the cyclic AMP response element","volume":"580","author":"Hogan","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.canlet.2014.09.001_bib0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/BJ20080782","article-title":"SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen receptor transactivation","volume":"416","author":"Xie","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2014.09.001_bib0165","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/nar\/gkp333","article-title":"Molecular characterization of SMILE as a novel corepressor of nuclear receptors","volume":"37","author":"Xie","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.canlet.2014.09.001_bib0170","doi-asserted-by":"crossref","first-page":"28762","DOI":"10.1074\/jbc.M109.034165","article-title":"Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation","volume":"284","author":"Xie","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.09.001_bib0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/me.2007-0194","article-title":"CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction","volume":"22","author":"Suh","year":"2008","journal-title":"Mol. Endocrinol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0180","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1074\/jbc.M113.491522","article-title":"Ursodeoxycholic acid inhibits liver X receptor alpha-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.09.001_bib0185","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.freeradbiomed.2009.09.004","article-title":"ROS inhibit the expression of testicular steroidogenic enzyme genes via the suppression of Nur77 transactivation","volume":"47","author":"Lee","year":"2009","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.canlet.2014.09.001_bib0190","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/me.2009-0188","article-title":"HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer","volume":"23","author":"Ai","year":"2009","journal-title":"Mol. Endocrinol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2407-14-52","article-title":"Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells","volume":"14","author":"Demir","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2014.09.001_bib0200","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1128\/MCB.18.9.5128","article-title":"Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription","volume":"18","author":"Moilanen","year":"1998","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.canlet.2014.09.001_bib0210","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1152\/ajpendo.00800.2007","article-title":"Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression","volume":"295","author":"Chanda","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2014.09.001_bib0215","doi-asserted-by":"crossref","first-page":"15369","DOI":"10.1021\/bi011384o","article-title":"Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP","volume":"40","author":"Gobinet","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2014.09.001_bib0220","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: a new perspective for an old antidiabetic drug?","volume":"9","author":"Ben Sahra","year":"2010","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2014.09.001_bib0225","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/carcin\/bgt307","article-title":"Metformin targets c-MYC oncogene to prevent prostate cancer","volume":"34","author":"Akinyeke","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2014.09.001_bib0230","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1038\/onc.2014.25","article-title":"Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model","volume":"33","author":"Nguyen","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.09.001_bib0235","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2014.09.001_bib0240","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/pros.22841","article-title":"Dihydrotestosterone enhances castration-resistant prostate cancer cell proliferation through STAT5 activation via glucocorticoid receptor pathway","volume":"74","author":"Song","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2014.09.001_bib0245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0165-4608(89)90055-1","article-title":"Cytogenetic analysis of four primary prostatic cultures","volume":"37","author":"Brothman","year":"1989","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1016\/j.canlet.2014.09.001_bib0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11060-008-9682-6","article-title":"Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis","volume":"91","author":"Valderrama","year":"2009","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.canlet.2014.09.001_bib0255","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bbrc.2009.12.059","article-title":"Amino acid deprivation induces CREBZF\/Zhangfei expression via an AARE-like element in the promoter","volume":"391","author":"Zhang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514004996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514004996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:38:42Z","timestamp":1650101922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383514004996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0304383514004996"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.09.001","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMILE upregulated by metformin inhibits the function of androgen receptor in prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}